{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:54:24Z","timestamp":1788051264100,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Program for graduates research of Bengbu Medical College","award":["(Grant No. Byycx22043\uff0cByycxz24018)."],"award-info":[{"award-number":["(Grant No. Byycx22043\uff0cByycxz24018)."]}]},{"name":"The Program for graduates research of Bengbu Medical College","award":["(Grant No. Byycx22043\uff0cByycxz24018)."],"award-info":[{"award-number":["(Grant No. Byycx22043\uff0cByycxz24018)."]}]},{"name":"The Natural Science Foundation of Anhui Province","award":["(Grant No. 2108085MH294)"],"award-info":[{"award-number":["(Grant No. 2108085MH294)"]}]},{"name":"the University Synergy Innovation Program of Anhui Province;","award":["(GXXT-2022-064)"],"award-info":[{"award-number":["(GXXT-2022-064)"]}]},{"name":"Climbing program in General project of Bengbu Medical College","award":["(Grant No. 2020bypd005)"],"award-info":[{"award-number":["(Grant No. 2020bypd005)"]}]},{"name":"The Natural Science General Project of Bengbu Medical University","award":["No. 2024byzd050"],"award-info":[{"award-number":["No. 2024byzd050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer is the most common type of cancer among women. It is well-established that microRNAs (miRNAs) play a critical role in cancer development by either degrading messenger RNA (mRNA) or inhibiting its translation, thereby suppressing the expression of specific genes. In this study, we found that the expression level of miR-142-3p was significantly lower in breast cancer cells and tissues than in normal breast epithelial cells and adjacent tissues. We demonstrated that miR-142-3p could inhibit the proliferation, migration, epithelial-mesenchymal transition (EMT), and stemness of MCF 7 breast cancer cells, while also promoting apoptosis. Further investigation revealed that miR-142-3p directly targets CXCL12 and regulates its expression. Silencing CXCL12 (using CXCL12 siRNA) suppressed the migration, EMT, and stemness of MCF 7 cells, and these effects were reversed by inhibition of miR-142-3p. Additionally, we observed alterations in \u03b2-catenin protein levels, suggesting that miR-142-3p may modulate the WNT\/\u03b2-catenin signaling pathway through targeting CXCL12 in MCF 7 cells. Subsequent experiments indicated that miR-142-3p also plays a crucial role in overcoming paclitaxel resistance in MCF 7\/PTX cells. SOX2 protein levels, which are associated with paclitaxel resistance, proliferation, migration, and EMT, were higher in MCF 7\/PTX cells compared to MCF 7 cells. Overall, our findings suggest that miR-142-3p influences breast cancer progression by targeting the CXCL12\/WNT\/\u03b2-catenin pathway, thereby affecting cell migration, EMT, stemness, and paclitaxel resistance.<\/jats:p>","DOI":"10.1038\/s41598-025-34163-4","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:45:33Z","timestamp":1767023133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MiR-142-3p targets the CXCL12\/WNT\/\u03b2-catenin pathway to regulate the stemness of breast cancer cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"1","key":"34163_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L. et al. Cancer statistics, 2023[J]. CA Cancer J. Clin. 73 (1), 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"34163_CR2","doi-asserted-by":"publisher","first-page":"113774","DOI":"10.1016\/j.biopha.2022.113774","volume":"155","author":"M Hashemi","year":"2022","unstructured":"Hashemi, M. et al. EMT mechanism in breast cancer metastasis and drug resistance: revisiting molecular interactions and biological functions[J]. Biomed. Pharmacother. 155, 113774. https:\/\/doi.org\/10.1016\/j.biopha.2022.113774 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"34163_CR3","doi-asserted-by":"publisher","unstructured":"Lee, K. L. et al. Triple-Negative breast cancer: current Understanding and future therapeutic breakthrough targeting cancer Stemness[J]. Cancers (Basel). 11 (9). https:\/\/doi.org\/10.3390\/cancers11091334 (2019).","DOI":"10.3390\/cancers11091334"},{"key":"34163_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13046-016-0359-2","volume":"35","author":"S Kaufhold","year":"2016","unstructured":"Kaufhold, S., Garban, H. & Bonavida, B. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication[J]. J. Exp. Clin. Cancer Res. 35, 84. https:\/\/doi.org\/10.1186\/s13046-016-0359-2 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"34163_CR5","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41556-022-00919-7","volume":"24","author":"M Cao","year":"2022","unstructured":"Cao, M. et al. Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth[J]. Nat. Cell. Biol. 24 (6), 954\u2013967. https:\/\/doi.org\/10.1038\/s41556-022-00919-7 (2022).","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"34163_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12943-022-01667-w","volume":"21","author":"H Ji","year":"2022","unstructured":"Ji, H. et al. Two circPPFIA1s negatively regulate liver metastasis of colon cancer via miR-155-5p\/CDX1 and HuR\/RAB36[J]. Mol. Cancer. 21 (1), 197. https:\/\/doi.org\/10.1186\/s12943-022-01667-w (2022).","journal-title":"Mol. Cancer"},{"issue":"11","key":"34163_CR7","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/s41418-022-01007-x","volume":"29","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Targeting the miR-34a\/LRPPRC\/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer[J]. Cell. Death Differ. 29 (11), 2177\u20132189. https:\/\/doi.org\/10.1038\/s41418-022-01007-x (2022).","journal-title":"Cell. Death Differ."},{"issue":"10","key":"34163_CR8","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.7150\/ijbs.83264","volume":"19","author":"Y Zou","year":"2023","unstructured":"Zou, Y. et al. Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway[J]. Int. J. Biol. Sci. 19 (10), 3099\u20133114. https:\/\/doi.org\/10.7150\/ijbs.83264 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"34163_CR9","doi-asserted-by":"publisher","first-page":"110566","DOI":"10.1016\/j.cellsig.2022.110566","volume":"103","author":"Y Shi","year":"2023","unstructured":"Shi, Y. et al. miR-142-3p improves Paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway[J]. Cell. Signal. 103, 110566. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110566 (2023).","journal-title":"Cell. Signal."},{"issue":"1","key":"34163_CR10","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/s41467-022-29151-5","volume":"13","author":"J Li","year":"2022","unstructured":"Li, J. et al. S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy[J]. Nat. Commun. 13 (1), 1481. https:\/\/doi.org\/10.1038\/s41467-022-29151-5 (2022).","journal-title":"Nat. Commun."},{"key":"34163_CR11","doi-asserted-by":"publisher","unstructured":"Chen, S. et al. Cancer\u2013associated fibroblast\u2013induced M2\u2013polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor\u20131 pathway[J]. Int. J. Oncol. 59 (2). https:\/\/doi.org\/10.3892\/ijo.2021.5239 (2021).","DOI":"10.3892\/ijo.2021.5239"},{"issue":"6","key":"34163_CR12","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.7150\/thno.52199","volume":"11","author":"W Feng","year":"2021","unstructured":"Feng, W. et al. CXCL12-mediated HOXB5 overexpression facilitates colorectal cancer metastasis through transactivating CXCR4 and ITGB3[J]. Theranostics 11 (6), 2612\u20132633. https:\/\/doi.org\/10.7150\/thno.52199 (2021).","journal-title":"Theranostics"},{"issue":"12","key":"34163_CR13","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.1002\/jcp.29755","volume":"235","author":"HF Wang","year":"2020","unstructured":"Wang, H. F. et al. The N-terminal polypeptide derived from vMIP-II exerts its antitumor activity in human breast cancer through CXCR4\/miR-7-5p\/Skp2 pathway[J]. J. Cell. Physiol. 235 (12), 9474\u20139486. https:\/\/doi.org\/10.1002\/jcp.29755 (2020).","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"34163_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3892\/ijo.2018.4477","volume":"53","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR\u2013155\u20133p and miR\u2013155-5p via the CXCR4 pathway in breast cancer[J]. Int. J. Oncol. 53 (3), 1043\u20131054. https:\/\/doi.org\/10.3892\/ijo.2018.4477 (2018).","journal-title":"Int. J. Oncol."},{"issue":"4","key":"34163_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/0008-5472.CAN-18-0620","volume":"79","author":"F Yang","year":"2019","unstructured":"Yang, F. et al. Inhibition of dipeptidyl Peptidase-4 accelerates Epithelial-Mesenchymal transition and breast cancer metastasis via the CXCL12\/CXCR4\/mTOR Axis[J]. Cancer Res. 79 (4), 735\u2013746. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0620 (2019).","journal-title":"Cancer Res."},{"key":"34163_CR16","doi-asserted-by":"publisher","first-page":"110884","DOI":"10.1016\/j.cellsig.2023.110884","volume":"111","author":"X Shi","year":"2023","unstructured":"Shi, X. et al. Exosome-derived miR-372-5p promotes stemness and metastatic ability of CRC cells by inducing macrophage polarization[J]. Cell. Signal. 111, 110884. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110884 (2023).","journal-title":"Cell. Signal."},{"issue":"1","key":"34163_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","volume":"19","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities[J]. Mol. Cancer. 19 (1), 165. https:\/\/doi.org\/10.1186\/s12943-020-01276-5 (2020).","journal-title":"Mol. Cancer"},{"issue":"4","key":"34163_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells[J]. Cell 133 (4), 704\u2013715. https:\/\/doi.org\/10.1016\/j.cell.2008.03.027 (2008).","journal-title":"Cell"},{"issue":"7955","key":"34163_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05838-7","volume":"616","author":"M Debaugnies","year":"2023","unstructured":"Debaugnies, M. et al. RHOJ controls EMT-associated resistance to chemotherapy[J]. Nature 616 (7955), 168\u2013175. https:\/\/doi.org\/10.1038\/s41586-023-05838-7 (2023).","journal-title":"Nature"},{"issue":"38","key":"34163_CR20","doi-asserted-by":"publisher","first-page":"16062","DOI":"10.1073\/pnas.1106704108","volume":"108","author":"E Vlashi","year":"2011","unstructured":"Vlashi, E. et al. Metabolic state of glioma stem cells and nontumorigenic cells[J]. Proc. Natl. Acad. Sci. U S A. 108 (38), 16062\u201316067. https:\/\/doi.org\/10.1073\/pnas.1106704108 (2011).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"34163_CR21","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s41467-022-29018-9","volume":"13","author":"M Wu","year":"2022","unstructured":"Wu, M. et al. Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis[J]. Nat. Commun. 13 (1), 1371. https:\/\/doi.org\/10.1038\/s41467-022-29018-9 (2022).","journal-title":"Nat. Commun."},{"issue":"8","key":"34163_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik, D. & Lathia, J. D. Cancer stem cell-immune cell crosstalk in tumour progression[J]. Nat. Rev. Cancer. 21 (8), 526\u2013536. https:\/\/doi.org\/10.1038\/s41568-021-00366-w (2021).","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"34163_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cac2.12138","volume":"41","author":"G Pan","year":"2021","unstructured":"Pan, G. et al. EMT-associated MicroRNAs and their roles in cancer stemness and drug resistance[J]. Cancer Commun. (Lond). 41 (3), 199\u2013217. https:\/\/doi.org\/10.1002\/cac2.12138 (2021).","journal-title":"Cancer Commun. (Lond)"},{"key":"34163_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biopha.2023","volume":"79","author":"B Li","year":"2016","unstructured":"Li, B. et al. miR-221\/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN\/Akt pathway[J]. Biomed. Pharmacother. 79, 93\u2013101. https:\/\/doi.org\/10.1016\/j.biopha.2023 (2016).","journal-title":"Biomed. Pharmacother"},{"issue":"13","key":"34163_CR25","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1111\/jcmm.15317","volume":"24","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2[J]. J. Cell. Mol. Med. 24 (13), 7353\u20137369. https:\/\/doi.org\/10.1111\/jcmm.15317 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"34163_CR26","doi-asserted-by":"publisher","unstructured":"Huang, Y. J. et al. Antrodia cinnamomea enhances Chemo-Sensitivity of 5-FU and suppresses colon tumorigenesis and cancer stemness via Up-Regulation of tumor suppressor miR-142-3p[J]. Biomolecules 9 (8). https:\/\/doi.org\/10.3390\/biom9080306 (2019).","DOI":"10.3390\/biom9080306"},{"issue":"8","key":"34163_CR27","doi-asserted-by":"publisher","first-page":"1392297777","DOI":"10.1177\/1010428318791887","volume":"40","author":"FM Troschel","year":"2018","unstructured":"Troschel, F. M. et al. miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro[J]. Tumour Biol. 40 (8), 1392297777. https:\/\/doi.org\/10.1177\/1010428318791887 (2018).","journal-title":"Tumour Biol."},{"issue":"4","key":"34163_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","volume":"146","author":"PB Gupta","year":"2011","unstructured":"Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells[J]. Cell 146 (4), 633\u2013644. https:\/\/doi.org\/10.1016\/j.cell.2011.07.026 (2011).","journal-title":"Cell"},{"issue":"1","key":"34163_CR29","doi-asserted-by":"publisher","first-page":"8doi","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. Targeting cancer stem cell pathways for cancer therapy[J]. Signal. Transduct. Target. Ther. 5 (1), 8doi. https:\/\/doi.org\/10.1038\/s41392-020-0110-5 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"34163_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1042\/EBC20220016","volume":"66","author":"M Katoh","year":"2022","unstructured":"Katoh, M. & Katoh, M. WNT signaling and cancer stemness[J]. Essays Biochem. 66 (4), 319\u2013331. https:\/\/doi.org\/10.1042\/EBC20220016 (2022).","journal-title":"Essays Biochem."},{"issue":"9","key":"34163_CR31","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1002\/jcp.29550","volume":"235","author":"S Deng","year":"2020","unstructured":"Deng, S. et al. miRNA-192 and \u2013\u2009215 activate Wnt\/beta-catenin signaling pathway in gastric cancer via APC[J]. J. Cell. Physiol. 235 (9), 6218\u20136229. https:\/\/doi.org\/10.1002\/jcp.29550 (2020).","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"34163_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/mc.23148","volume":"59","author":"X Si","year":"2020","unstructured":"Si, X. et al. SOX2 upregulates side population cells and enhances their chemoresistant ability by transactivating ABCC1 expression contributing to intrinsic resistance to Paclitaxel in melanoma[J]. Mol. Carcinog. 59 (3), 257\u2013264. https:\/\/doi.org\/10.1002\/mc.23148 (2020).","journal-title":"Mol. Carcinog."},{"key":"34163_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2019.03.027","volume":"452","author":"L Li","year":"2019","unstructured":"Li, L. et al. Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer[J]. Cancer Lett. 452, 191\u2013202. https:\/\/doi.org\/10.1016\/j.canlet.2019.03.027 (2019).","journal-title":"Cancer Lett."},{"issue":"2","key":"34163_CR34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.7150\/ijbs.76187","volume":"19","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Targeting breast cancer stem Cells[J]. Int. J. Biol. Sci. 19 (2), 552\u2013570. https:\/\/doi.org\/10.7150\/ijbs.76187 (2023).","journal-title":"Int. J. Biol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34163-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:55:38Z","timestamp":1781625338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34163-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34163"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34163-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3963"}}